The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Open accessAbstract
Background: High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) and support advocacy efforts. Objectives: The Atlas of MS is an open-source global compendium of data regarding the epidemiology of MS and the availability of resources for people with MS reported at country, regional and global levels. Methods: Country representatives reported epidemiologic data and their sources via survey between September 2019 and March 2020, covering prevalence and incidence in males, females and children, and age and MS type at diagnosis. Regional analyses and comparisons with 2013 data were conducted. Results: A total of 2.8 million people are estimated to live with MS worldwide (35.9 per 100,000 population). MS prevalence has increased in every world region since 2013 but gaps in prevalence estimates persist. The pooled incidence rate across 75 reporting countries is 2.1 per 100,000 persons/year, and the mean age of diagnosis is 32 years. Females are twice as likely to live with MS as males. Conclusions: The global prevalence of MS has risen since 2013, but good surveillance data is not universal. Action is needed by multiple stakeholders to close knowledge gaps.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., & Thompson, A. J. (2014) · Neurology · doi:10.1212/wnl.0000000000000768 · Cited by 1,223
Wallin, M. T., Culpepper, W. J., Nichols, E., Bhutta, Z. A., Gebrehiwot, T. T., Hay, S. I., Khalil, I. A., Krohn, K. J., Liang, X., Naghavi, M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30443-5 · Cited by 1,134
Self-citationThe prevalence of MS in the United States: A population-based estimate using health claims data
Wallin, M. T., Culpepper, W. J., Campbell, J. D., Nelson, L. M., Langer-Gould, A., Marrie, R. A., Cutter, G. R., Kaye, W. E., Wagner, L., Tremlett, H., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007035 · Cited by 1,098
Self-citationSurvival in MS: A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial
Goodin, D. S., Reder, A. T., Ebers, G. C., Cutter, G., Kremenchutzky, M., Oger, J., Langdon, D., Rametta, M., Beckmann, K., DeSimone, T. M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535cf6 · Cited by 249
Kingwell, E., Zhu, F., Marrie, R. A., Fisk, J. D., Wolfson, C. M., Warren, S., Profetto‐McGrath, J., Svenson, L. W., Jetté, N., Bhan, V., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7842-0 · Cited by 133
Self-citationBeiki, O., Frumento, P., Bottai, M., Manouchehrinia, A., & Hillert, J. A. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0330 · Cited by 84
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region
Yamout, B., Assaad, W., Tamim, H., Mrabet, S., & Goueider, R. (2020) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217319841881 · Cited by 67
Campbell, J. A., Simpson, S., Ahmad, H., Taylor, B. V., van der Mei, I. A. F., & Palmer, A. J. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519861270 · Cited by 57
Research works printed but not linked: 2
- Yamout B, 2020, Mult Scler J Exp Transl Clin, 6
- 10.3390/brainsci10050305 · doi:10.3390/brainsci10050305
Cited by
Adamu, A., Li, S., Gao, F., & Xue, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1347987 · Cited by 564
Epstein–Barr virus and multiple sclerosis
Soldan, S. S., & Lieberman, P. M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00770-5 · Cited by 467
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Locus for severity implicates CNS resilience in progression of multiple sclerosis
International Multiple Sclerosis Genetics Consortium, Harroud, A., Stridh, P., McCauley, J. L., Saarela, J., van den Bosch, A. M. R., Engelenburg, H. J., Beecham, A. H., Alfredsson, L., Alikhani, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06250-x · Cited by 243
Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations
Barrie, W., Yang, Y., Irving-Pease, E. K., Attfield, K. E., Scorrano, G., Jensen, L. T., Armen, A. P., Dimopoulos, E. A., Stern, A., Refoyo-Martinez, A., et al. (2024) · Nature · doi:10.1038/s41586-023-06618-z · Cited by 161
Metadata
- Authors
- Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., & Baneke, P.
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2020-11-11
- Volume
- 26
- Issue
- 14
- Pages
- 1816-1821
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W3099273656
- Cited by
- 2,653
- References
- 8
- FWCI
- 135.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Biogen
- Novartis
- Vanneau Trust
- Associazione Italiana Sclerosi Multipla
- Multiple Sclerosis Society
- Merck
- Bristol-Myers Squibb
- Sanofi
- National Multiple Sclerosis Society
- Roche
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. https://app.cochat.ai/papers/10.1177/1352458520970841
- The paper
- Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., & Baneke, P. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458520970841
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.